Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
Holding CAMP?
Track your performance easily
CAMP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.80 - $12.30
Previous Close$8.12
Volume16.59K
Average Volume (3M)110.62K
Market Cap
$147.46M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume110,622
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$19.33Price Target Upside155.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
CAMP4 Therapeutics Corporation News
PremiumCompany Announcements
CalAmp’s Restructuring Journey: Debt, Bankruptcy, and Future
Bulls Say, Bears Say
Bulls Say
Competitive AdvantageCMP-CPS-001 has the ability to replace poorly performing, burdensome nitrogen scavenger therapy with a convenient monthly SC injection, and with a wider addressable population and favorable safety profile.
Innovative TherapeuticsCAMP4 is pioneering development of regulatory RNAs (regRNAs) as a novel therapeutic modality.
Market OpportunityCMP-CPS-001 has a larger total addressable market and meets a high unmet need in urea cycle disorders, which presents an upside risk and reward opportunity.
Bears Say
Clinical TrialsIf CMP-CPS-001 fails to meaningfully increase ureagenesis, there could be a significant downside to the price target as CAMP trades to cash.
Financial StabilityCAMP4 may need additional capital or face future litigation.
Regulatory ApprovalRegRNA therapies may fail in the clinic or to gain approval.
---
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CAMP FAQ
What was CAMP4 Therapeutics Corporation’s price range in the past 12 months?
CAMP4 Therapeutics Corporation lowest stock price was $7.80 and its highest was $12.30 in the past 12 months.
What is CAMP4 Therapeutics Corporation’s market cap?
Currently, no data Available
When is CAMP4 Therapeutics Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CAMP4 Therapeutics Corporation’s earnings last quarter?
Currently, no data Available
Is CAMP4 Therapeutics Corporation overvalued?
According to Wall Street analysts CAMP4 Therapeutics Corporation’s price is currently Undervalued.
Does CAMP4 Therapeutics Corporation pay dividends?
CAMP4 Therapeutics Corporation does not currently pay dividends.
What is CAMP4 Therapeutics Corporation’s EPS estimate?
CAMP4 Therapeutics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CAMP4 Therapeutics Corporation have?
CAMP4 Therapeutics Corporation has 19,505,120 shares outstanding.
What happened to CAMP4 Therapeutics Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CAMP4 Therapeutics Corporation?
Currently, no hedge funds are holding shares in CAMP
---
CAMP4 Therapeutics Corporation Stock Smart Score
CAMP Stock 12 Month Forecast
Average Price Target
$19.33
▲(155.69% Upside)
Technical Analysis
Best Analysts Covering CAMP
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+25.90%
initiated a buy rating 14 days ago
Copying Myles Minter's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.90% per trade.
---